We are live on ! Find out more
CSII

Cardiovascular Systems, Inc.

Delisted

CSII was delisted on the 27th of April, 2023.

120 hedge funds and large institutions have $654M invested in Cardiovascular Systems, Inc. in 2014 Q2 according to their latest regulatory filings, with 18 funds opening new positions, 45 increasing their positions, 41 reducing their positions, and 29 closing their positions.

New
Increased
Maintained
Reduced
Closed

35% more call options, than puts

Call options by funds: $1.21M | Put options by funds: $890K

33% more funds holding in top 10

Funds holding in top 10: 34 (+1)

10% more repeat investments, than reductions

Existing positions increased: 45 | Existing positions reduced: 41

3% more capital invested

Capital invested by funds: $634M → $654M (+$20.1M)

8% less funds holding

Funds holding: 131120 (-11)

38% less first-time investments, than exits

New positions opened: 18 | Existing positions closed: 29

Holders
120
Holders Change
-11
Holders Change %
-8.4%
% of All Funds
3.45%
Holding in Top 10
4
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+33.33%
% of All Funds
0.11%
New
18
Increased
45
Reduced
41
Closed
29
Calls
$1.21M
Puts
$890K
Net Calls
+$315K
Net Calls Change
-$2.19M
Name Holding Trade Value Shares
Change
Change in
Stake
NFA
51
Nationwide Fund Advisors
Ohio
$1.83M +$275K +9,548 +19%
Bank of America
52
Bank of America
North Carolina
$1.7M +$69.7K +2,418 +5%
EAM
53
Eventide Asset Management
Massachusetts
$1.64M
PCM
54
Penn Capital Management
Pennsylvania
$1.63M +$1.51M +52,391 New
California State Teachers Retirement System (CalSTRS)
55
California State Teachers Retirement System (CalSTRS)
California
$1.57M +$89.4K +3,100 +7%
GPCM
56
Granite Point Capital Management
Massachusetts
$1.56M -$1.67M -58,000 -54%
EI
57
EAM Investors
California
$1.41M -$2.22M -76,913 -63%
Thrivent Financial for Lutherans
58
Thrivent Financial for Lutherans
Minnesota
$1.39M +$1.28M +44,506 New
Renaissance Technologies
59
Renaissance Technologies
New York
$1.34M -$80.7K -2,800 -6%
TA
60
Teachers Advisors
New York
$1.22M +$9.26K +321 +0.8%
Morgan Stanley
61
Morgan Stanley
New York
$1.19M -$870K -30,185 -44%
D.E. Shaw & Co
62
D.E. Shaw & Co
New York
$1.17M -$4.89M -169,523 -82%
HI
63
HBK Investments
Texas
$1.13M -$81.3K -2,821 -7%
Goldman Sachs
64
Goldman Sachs
New York
$1.06M -$304K -10,535 -24%
Cambridge Investment Research Advisors
65
Cambridge Investment Research Advisors
Iowa
$943K +$2.88K +100 +0.3%
NCCM
66
Nine Chapters Capital Management
New Jersey
$938K -$228K -7,900 -21%
MAM
67
Meeder Asset Management
Ohio
$919K
Swiss National Bank
68
Swiss National Bank
Switzerland
$888K +$77.8K +2,700 +10%
Citadel Advisors
69
Citadel Advisors
Florida
$865K +$504K +17,463 +170%
GC
70
Globeflex Capital
California
$813K +$753K +26,100 New
CS
71
Credit Suisse
Switzerland
$737K -$619K -21,461 -48%
RhumbLine Advisers
72
RhumbLine Advisers
Massachusetts
$728K +$60.5K +2,098 +10%
California Public Employees Retirement System
73
California Public Employees Retirement System
California
$689K
USAA
74
United Services Automobile Association
Texas
$673K +$623K +21,592 New
PPA
75
Parametric Portfolio Associates
Washington
$664K -$18.5K -640 -3%

CSII Hedge Fund Activity: Q2 2014 in Review

120 of the 3,479 institutional investors tracked by Wall St. Rank reported a position in Cardiovascular Systems, Inc. (CSII) for Q2 2014, worth a combined $654M — up 3.2% from $634M a quarter earlier.

Sellers outnumbered buyers: 29 funds closed out of CSII and 18 opened new positions — a net loss of 11 holders — while 41 trimmed existing stakes and 45 added.

The largest buyer was Consonance Capital Management, opening a new position worth an estimated $46.9M. The largest seller was Columbia Partners Investment Management, cutting an estimated $9.58M.

  • 120 institutional investors held Cardiovascular Systems, Inc. (CSII) as of Q2 2014, down from 131 in Q1 2014.
  • Funds reported $654M of Cardiovascular Systems, Inc. stock for Q2 2014, up 3.2% quarter-over-quarter.
  • 18 funds opened new Cardiovascular Systems, Inc. positions in Q2 2014 and 29 closed out, a net change of -11 holders.
  • The largest Cardiovascular Systems, Inc. buyer in Q2 2014 was Consonance Capital Management, an estimated $46.9M added.
  • The largest Cardiovascular Systems, Inc. seller in Q2 2014 was Columbia Partners Investment Management, an estimated $9.58M sold.

Based on aggregated 13F filings for Q2 2014.